• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Urgent Care
  • Patient Portal
  • Pay Your Bill
Loudoun Medical Group

Loudoun Medical Group

  • About LMG
    • About Us
    • Locations
    • Board of Directors
    • LMG Charitable Foundation
    • News
    • Awards & Accreditations
    • Annual Report
  • For Patients
    • Find a Provider
    • Pay My Bill
    • Patient Portal
    • Patient Forms & Info
      • Download Forms
      • Patient Satisfaction Survey
      • Patient-Centered Medical Home
      • No Surprises Act
    • Health Library
  • Healthcare Professionals
    • For Physicians
    • LMG Employees
      • Employee Portal
      • Manager Portal
    • Careers
    • Scrubs Plus
  • Contact

Loudoun Medical Group Accountable Care Organization

ACO Name and Location

Loudoun Medical Group ACO LLC
Previous Names: N/A
224D Cornwall St NW
Ste 403
Leesburg, VA 20176

ACO Primary Contact

Primary Contact NameMary Beth Tamasy, CEO
Primary Contact Phone Number703-737-6006
Primary Contact Email Addressmtamasy@lmgdoctors.com

Organizational Information

ACO ParticipantsACO Participant in Joint Venture (Enter Y or N)
Loudoun Medical Group PCN

ACO Governing Body:

MemberMember’s Voting Power*Membership TypeACO Participant** 
Last NameFirst NameTitle/Position
Crowley, MDAnthonyChairman1.00ACO Participant Representative

Loudoun Medical Group PC

Calihan, MDMarthaVoting Member1.00ACO Participant Representative

Loudoun Medical Group PC

Kuo, MDMichaelVoting Member1.00ACO Participant Representative

Loudoun Medical Group PC

Hetzel, MDRobertVoting Member1.00ACO Participant Representative

Loudoun Medical Group PC

Mellis, MDMichael G.Voting Member1.00ACO Participant Representative

Loudoun Medical Group PC

Beloy, MDAmieVoting Member1.00ACO Participant Representative

Loudoun Medical Group PC

Nekoba, MDJeffreyVoting Member1.00ACO Participant Representative

Loudoun Medical Group PC

Thompson, MDJennifer B.Voting Member1.00ACO Participant Representative

Loudoun Medical Group PC

Akhtar, MDNaumanVoting Member1.00ACO Participant Representative

Loudoun Medical Group PC

TamasyMary BethVoting Member1.00ACO Participant Representative

Loudoun Medical Group PC

KearnsKathrynVoting Member1.00Medicare Beneficiary Representative

Loudoun Medical Group PC

* Expressed as a percentage or number
** Legal Business Name/DBA, if Applicable

Key ACO Clinical and Administrative Leadership:

Mary Beth TamasyACO Executive
Anthony CrowleyMedical Director
Clara NussbaumCompliance Officer
Clara NussbaumQuality Assurance/Improvement Officer

Associated Committees and Committee Leadership:

Quality Assurance and Improvement Committee – Anthony Crowley, MD, Chair
Finance Committee –  Robert Hetzel, MD, Chair
Communications Committee – Linda Coleman, MD, Chair


Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement

Amount of Shared Savings/Losses:

  • Third Agreement Period
    • Performance Year 2020, $0
  • Second Agreement Period
    • Performance Year 2019, $0
    • Performance Year 2018, $0
    • Performance Year 2017, $1,272,644
  • Second Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution:

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A 
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: N/A 
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants N/A
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A 
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A 
    • Performance Year 2017
      • Proportion invested in infrastructure: 30% 
      • Proportion invested in redesigned care processes/resources: 30%
      • Proportion of distribution to ACO participants: 40%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A  
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A 
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A 
      • Proportion invested in redesigned care processes/resources: N/A 
      • Proportion of distribution to ACO participants: N/A 
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A 
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

 


Quality Performance Results

2020 Quality Performance Results:

You may need to scroll horizontally to view all of the data.

2020 Quality Performance Results:

ACO #Measure NameRateACO Mean
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))0.940.95
ACO-13Falls: Screening for Future Fall Risk77.6084.97
ACO-14Preventive Care and Screening: Influenza Immunization66.8076.03
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention28.5781.67
ACO-18Preventive Care and Screening: Screening for Depression and Follow-up Plan31.3471.46
ACO-19Colorectal Cancer Screening65.5672.59
ACO-20Breast Cancer Screening57.5874.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease81.5083.37
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control12.2514.70
ACO-28Hypertension (HTN): Controlling High Blood Pressure69.2072.87

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

Footer

  • Facebook
  • LinkedIn
  • Twitter
  • For Patients
  • Become an LMG Practice
  • Careers
  • Awards and Accreditations
  • News
  • Contact LMG
  • (703) 443-6717Billing Inquiries
  • Contact LMG
  • Patient Portal
  • Support
  • Pay Your Bill
  • Find a Provider
  • LMG Careers
  • Become A Provider
  • Employees

Copyright 2022 Loudoun Medical Group · All Rights Reserved.
Website Development and Management by MarketSpark. Admin